Philip Insel, PhD, MS

Title(s)Assistant Professor, Psychiatry
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Speech patterns during memory recall relates to early tau burden across adulthood. Alzheimers Dement. 2024 Feb 13. Young CB, Smith V, Karjadi C, Grogan SM, Ang TFA, Insel PS, Henderson VW, Sumner M, Poston KL, Au R, Mormino EC. PMID: 38348772.
      View in: PubMed   Mentions:    Fields:    
    2. Anxiety in late-life depression: Associations with brain volume, amyloid beta, white matter lesions, cognition, and functional ability. Int Psychogeriatr. 2024 Jan 25; 1-12. Kryza-Lacombe M, Kassel MT, Insel PS, Rhodes E, Bickford D, Burns E, Butters MA, Tosun D, Aisen P, Raman R, Landau S, Saykin AJ, Toga AW, Jack CR, Koeppe R, Weiner MW, Nelson C, Mackin RS. PMID: 38268483.
      View in: PubMed   Mentions:    Fields:    
    3. Relationship of Hoarding and Depression Symptoms in Older Adults. Am J Geriatr Psychiatry. 2024 Apr; 32(4):497-508. Nutley S, Nguyen BK, Mackin RS, Insel PS, Tosun D, Butters M, Aisen P, Raman R, Saykin AJ, Toga AW, Jack C, Weiner MW, Nelson C, Kassel M, Kryza-Lacombe M, Eichenbaum J, Nosheny RL, Mathews CA. PMID: 38092621.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Hoarding Symptoms in Late Life Depression are Associated With Greater Executive Dysfunction and Disability and Poorer Response to Depression Treatment. Am J Geriatr Psychiatry. 2024 02; 32(2):137-147. Kassel MT, Kryza-Lacombe M, Insel PS, Rhodes E, Satre DD, Nelson JC, Tosun D, Mathews CA, Mackin RS. PMID: 37770349; PMCID: PMC10872841.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease. Neurology. 2023 07 04; 101(1):e20-e29. Insel PS, Kumar A, Hansson O, Mattsson-Carlgren N, Alzheimer's Disease Neuroimaging Initiative. PMID: 37085326; PMCID: PMC10351305.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Tau positron emission tomography in preclinical Alzheimer's disease. Brain. 2023 02 13; 146(2):700-711. Insel PS, Young CB, Aisen PS, Johnson KA, Sperling RA, Mormino EC, Donohue MC. PMID: 35962782; PMCID: PMC10169284.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    7. Natural cubic splines for the analysis of Alzheimer's clinical trials. Pharm Stat. 2023 May-Jun; 22(3):508-519. Donohue MC, Langford O, Insel PS, van Dyck CH, Petersen RC, Craft S, Sethuraman G, Raman R, Aisen PS, Alzheimer's Disease Neuroimaging Initiative. PMID: 36627206; PMCID: PMC10191992.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. APOE effects on regional tau in preclinical Alzheimer's disease. Mol Neurodegener. 2023 01 04; 18(1):1. Young CB, Johns E, Kennedy G, Belloy ME, Insel PS, Greicius MD, Sperling RA, Johnson KA, Poston KL, Mormino EC, Alzheimer’s Disease Neuroimaging Initiative, A4 Study Team. PMID: 36597122; PMCID: PMC9811772.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    9. The genetic regulation of protein expression in cerebrospinal fluid. EMBO Mol Med. 2022 Dec 12; e16359. Hansson O, Kumar A, Janelidze S, Stomrud E, Insel PS, Blennow K, Zetterberg H, Fauman E, Hedman ÅK, Nagle MW, Whelan CD, Baird D, Mälarstig A, Mattsson-Carlgren N. PMID: 36504281.
      View in: PubMed   Mentions: 7     Fields:    
    10. Uncertainties in the PET defined A-/TNeocortical+ subtype. Alzheimers Dement (Amst). 2022; 14(1):e12348. Mormino EC, Insel PS. PMID: 36051175; PMCID: PMC9413468.
      View in: PubMed   Mentions:
    11. Cognitive outcomes are differentially associated with depression severity trajectories during psychotherapy treatment for late life major depressive disorder. Int J Geriatr Psychiatry. 2022 08; 37(8). Kassel MT, Rhodes E, Insel PS, Woodworth K, Garrison-Diehn C, Satre DD, Nelson JC, Tosun D, Mackin RS. PMID: 35822633; PMCID: PMC10162695.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Brain. 2021 10 22; 144(9):2771-2783. Berron D, Vogel JW, Insel PS, Pereira JB, Xie L, Wisse LEM, Yushkevich PA, Palmqvist S, Mattsson-Carlgren N, Stomrud E, Smith R, Strandberg O, Hansson O. PMID: 33725124; PMCID: PMC8557349.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    13. Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults. JAMA Netw Open. 2021 07 01; 4(7):e2117573. Insel PS, Mohlenhoff BS, Neylan TC, Krystal AD, Mackin RS. PMID: 34297074; PMCID: PMC8303100.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    14. Reliability and Validity of a Home-Based Self-Administered Computerized Test of Learning and Memory Using Speech Recognition. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2022 09; 29(5):867-881. Mackin RS, Rhodes E, Insel PS, Nosheny R, Finley S, Ashford M, Camacho MR, Truran D, Mosca K, Seabrook G, Morrison R, Narayan VA, Weiner M. PMID: 34139954; PMCID: PMC10081827.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    15. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging. 2021 07; 48(7):2295-2305. Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N, Benedet AL, Cho H, Lyoo CH, La Joie R, Rabinovici GD, Ossenkoppele R, Rosa-Neto P, Hansson O. PMID: 34041562; PMCID: PMC8175317.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    16. Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging. Alzheimers Res Ther. 2021 04 19; 13(1):82. Lopes Alves I, Heeman F, Collij LE, Salvadó G, Tolboom N, Vilor-Tejedor N, Markiewicz P, Yaqub M, Cash D, Mormino EC, Insel PS, Boellaard R, van Berckel BNM, Lammertsma AA, Barkhof F, Gispert JD. PMID: 33875021; PMCID: PMC8056524.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    17. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment. JAMA Neurol. 2021 02 01; 78(2):229-235. Insel PS, Hansson O, Mattsson-Carlgren N. PMID: 33044487; PMCID: PMC7551211.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    18. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease. Transl Psychiatry. 2021 01 26; 11(1):76. Johansson M, Stomrud E, Insel PS, Leuzy A, Johansson PM, Smith R, Ismail Z, Janelidze S, Palmqvist S, van Westen D, Mattsson-Carlgren N, Hansson O. PMID: 33500386; PMCID: PMC7838407.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    19. The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression. J Alzheimers Dis. 2021; 80(3):991-1002. Rhodes E, Insel PS, Butters MA, Morin R, Bickford D, Tosun D, Gessert D, Rosen HJ, Aisen P, Raman R, Landau S, Saykin A, Toga A, Jack CR, Weiner MW, Nelson C, Mackin S, Alzheimer’s Disease Neuroimaging Initiative, ADNI Depression Project. PMID: 33682706; PMCID: PMC8935860.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    20. Time between milestone events in the Alzheimer's disease amyloid cascade. Neuroimage. 2021 02 15; 227:117676. Insel PS, Donohue MC, Berron D, Hansson O, Mattsson-Carlgren N. PMID: 33359337.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    21. Reply to: Brain Amyloid Deposition in Late-Life Depression. Biol Psychiatry. 2021 04 15; 89(8):e43-e44. Mackin RS, Insel PS. PMID: 33189331; PMCID: PMC8444625.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Comparing progression biomarkers in clinical trials of early Alzheimer's disease. Ann Clin Transl Neurol. 2020 09; 7(9):1661-1673. Cullen NC, Zetterberg H, Insel PS, Olsson B, Andreasson U, Alzheimer’s Disease Neuroimaging Initiative, Blennow K, Hansson O, Mattsson-Carlgren N. PMID: 32779869; PMCID: PMC7480920.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    23. Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project. Biol Psychiatry. 2021 04 15; 89(8):757-765. Mackin RS, Insel PS, Landau S, Bickford D, Morin R, Rhodes E, Tosun D, Rosen HJ, Butters M, Aisen P, Raman R, Saykin A, Toga A, Jack C, Koeppe R, Weiner MW, Nelson C, Alzheimer’s Disease Neuroimaging Initiative and the ADNI Depression Project. PMID: 32980132; PMCID: PMC10165941.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    24. The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults. Ann Clin Transl Neurol. 2020 05; 7(5):776-785. Insel PS, Donohue MC, Sperling R, Hansson O, Mattsson-Carlgren N. PMID: 32315118; PMCID: PMC7261742.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    25. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease. Sci Adv. 2020 04; 6(16):eaaz2387. Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, Zetterberg H, Rosen HJ, Rabinovici G, Chai X, Blennow K, Dage JL, Stomrud E, Smith R, Palmqvist S, Hansson O. PMID: 32426454; PMCID: PMC7159908.
      View in: PubMed   Mentions: 117     Fields:    Translation:AnimalsCells
    26. Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention. Brain Commun. 2020; 2(1):fcaa007. Insel PS, Mormino EC, Aisen PS, Thompson WK, Donohue MC. PMID: 32140682; PMCID: PMC7048875.
      View in: PubMed   Mentions: 40  
    27. Depression Severity, but Not Cognitive Impairment or Frailty, is Associated with Disability in Late-Life Depression. Clin Gerontol. 2020 Jul-Sep; 43(4):411-419. Morin RT, Insel P, Bickford D, Nelson C, Mackin RS. PMID: 31865868; PMCID: PMC9187219.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Study partner-reported decline identifies cognitive decline and dementia risk. Ann Clin Transl Neurol. 2019 12; 6(12):2448-2459. Nosheny RL, Jin C, Neuhaus J, Insel PS, Mackin RS, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative investigators. PMID: 31721455; PMCID: PMC6917311.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    29. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease. EMBO Mol Med. 2019 12; 11(12):e11170. Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, Eichenlaub U, Dage JL, Chai X, Blennow K, Mattsson N, Hansson O. PMID: 31709776; PMCID: PMC6895602.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    30. β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly. Sci Rep. 2019 08 01; 9(1):11180. Svenningsson AL, Stomrud E, Insel PS, Mattsson N, Palmqvist S, Hansson O. PMID: 31371787; PMCID: PMC6671981.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    31. Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults. Neurobiol Aging. 2019 10; 82:110-119. Nosheny RL, Insel PS, Mattsson N, Tosun D, Buckley S, Truran D, Schuff N, Aisen PS, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 31437719; PMCID: PMC7198229.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    32. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019 07 23; 93(4):e322-e333. Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N. PMID: 31289148; PMCID: PMC6669933.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    33. Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia. J Int Neuropsychol Soc. 2019 09; 25(8):811-820. Morin RT, Insel P, Nelson C, Butters M, Bickford D, Landau S, Saykin A, Weiner M, Mackin RS, ADNI Depression Project. PMID: 31232250; PMCID: PMC6733620.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Somatic and anxiety symptoms of depression are associated with disability in late life depression. Aging Ment Health. 2020 08; 24(8):1225-1228. Morin RT, Nelson C, Bickford D, Insel PS, Mackin RS. PMID: 30945553; PMCID: PMC9183787.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease. Alzheimers Dement. 2019 04; 15(4):570-580. Mattsson N, Insel PS, Donohue M, Jögi J, Ossenkoppele R, Olsson T, Schöll M, Smith R, Hansson O. PMID: 30639421.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    36. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease. Neurology. 2019 02 05; 92(6):e601-e612. Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, Palmqvist S, Hansson O. PMID: 30626656; PMCID: PMC6382060.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    37. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest. JAMA Neurol. 2019 01 01; 76(1):64-71. Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, Dragancea I, Friberg H, Lilja G, Insel PS, Rylander C, Westhall E, Kjaergaard J, Wise MP, Hassager C, Kuiper MA, Stammet P, Wanscher MCJ, Wetterslev J, Erlinge D, Horn J, Pellis T, Cronberg T. PMID: 30383090; PMCID: PMC6440255.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    38. Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms. Alzheimers Dement. 2019 02; 15(2):194-204. Palmqvist S, Insel PS, Zetterberg H, Blennow K, Brix B, Stomrud E, Alzheimer's Disease Neuroimaging Initiative, Swedish BioFINDER study, Mattsson N, Hansson O. PMID: 30365928; PMCID: PMC6374284.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    39. Online study partner-reported cognitive decline in the Brain Health Registry. Alzheimers Dement (N Y). 2018; 4:565-574. Nosheny RL, Camacho MR, Insel PS, Flenniken D, Fockler J, Truran D, Finley S, Ulbricht A, Maruff P, Yaffe K, Mackin RS, Weiner MW. PMID: 30386821; PMCID: PMC6205111.
      View in: PubMed   Mentions: 25  
    40. Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults. J Clin Sleep Med. 2018 09 15; 14(9):1587-1594. Mohlenhoff BS, Insel PS, Mackin RS, Neylan TC, Flenniken D, Nosheny R, Richards A, Maruff P, Weiner MW. PMID: 30176964; PMCID: PMC6134252.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease. Neurobiol Aging. 2018 11; 71:81-90. Mattsson N, Eriksson O, Lindberg O, Schöll M, Lampinen B, Nilsson M, Insel PS, Lautner R, Strandberg O, van Westen D, Zetterberg H, Blennow K, Palmqvist S, Stomrud E, Hansson O. PMID: 30107289.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    42. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment. Int J Geriatr Psychiatry. 2018 10; 33(10):1305-1311. Gonzales MM, Insel PS, Nelson C, Tosun D, Schöll M, Mattsson N, Sacuiu S, Bickford D, Weiner MW, Mackin RS, Alzheimer's Disease Neuroimaging Initiative. PMID: 29953668.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry. Alzheimers Dement (Amst). 2018; 10:573-582. Mackin RS, Insel PS, Truran D, Finley S, Flenniken D, Nosheny R, Ulbright A, Comacho M, Bickford D, Harel B, Maruff P, Weiner MW. PMID: 30406176; PMCID: PMC6215059.
      View in: PubMed   Mentions: 42  
    44. The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018 08; 14(8):1063-1076. Weiner MW, Nosheny R, Camacho M, Truran-Sacrey D, Mackin RS, Flenniken D, Ulbricht A, Insel P, Finley S, Fockler J, Veitch D. PMID: 29754989; PMCID: PMC6126911.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    45. Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease. Neurology. 2018 01 30; 90(5):e388-e395. Mattsson N, Smith R, Strandberg O, Palmqvist S, Schöll M, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Blennow K, Jögi J, Hansson O. PMID: 29321235; PMCID: PMC5791788.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    46. Amyloid pathology in the progression to mild cognitive impairment. Neurobiol Aging. 2018 04; 64:76-84. Insel PS, Hansson O, Mackin RS, Weiner M, Mattsson N, Alzheimer's Disease Neuroimaging Initiative. PMID: 29353101; PMCID: PMC5820200.
      View in: PubMed   Mentions: 10     Fields:    
    47. Serum tau and neurological outcome in cardiac arrest. Ann Neurol. 2017 Nov; 82(5):665-675. Mattsson N, Zetterberg H, Nielsen N, Blennow K, Dankiewicz J, Friberg H, Lilja G, Insel PS, Rylander C, Stammet P, Aneman A, Hassager C, Kjaergaard J, Kuiper M, Pellis T, Wetterslev J, Wise M, Cronberg T. PMID: 28981963; PMCID: PMC5725735.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    48. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations. Alzheimers Res Ther. 2017 Oct 23; 9(1):87. Lautner R, Insel PS, Skillbäck T, Olsson B, Landén M, Frisoni GB, Herukka SK, Hampel H, Wallin A, Minthon L, Hansson O, Blennow K, Mattsson N, Zetterberg H. PMID: 29061195; PMCID: PMC5654097.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    49. 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease. EMBO Mol Med. 2017 09; 9(9):1212-1223. Mattsson N, Schöll M, Strandberg O, Smith R, Palmqvist S, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Jögi J, Blennow K, Hansson O. PMID: 28743782; PMCID: PMC5582410.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    50. Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Front Neurosci. 2017; 11:281. Insel PS, Ossenkoppele R, Gessert D, Jagust W, Landau S, Hansson O, Weiner MW, Mattsson N, Alzheimer's Disease Neuroimaging Initiative. PMID: 28567001; PMCID: PMC5434146.
      View in: PubMed   Mentions: 37  
    51.  Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression. Am J Geriatr Psychiatry. 2017 Sep; 25(9):980-991. Gonzales MM, Insel PS, Nelson C, Tosun D, Mattsson N, Mueller SG, Sacuiu S, Bickford D, Weiner MW, Mackin RS, Alzheimer's Disease Neuroimaging Initiative. PMID: 28629965; PMCID: PMC10079284.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    52. Cross-validation of optimized composites for preclinical Alzheimer's disease. Alzheimers Dement (N Y). 2017 Jan; 3(1):123-129. Donohue MC, Sun CK, Raman R, Insel PS, Aisen PS, AN-ADNI, AIBL, J-ADNI. PMID: 28758145; PMCID: PMC5527287.
      View in: PubMed   Mentions: 16  
    53. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease. EMBO Mol Med. 2016 10; 8(10):1184-1196. Mattsson N, Insel PS, Palmqvist S, Portelius E, Zetterberg H, Weiner M, Blennow K, Hansson O, Alzheimer's Disease Neuroimaging Initiative. PMID: 27534871; PMCID: PMC5048367.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    54. Plasma tau in Alzheimer disease. Neurology. 2016 Oct 25; 87(17):1827-1835. Mattsson N, Zetterberg H, Janelidze S, Insel PS, Andreasson U, Stomrud E, Palmqvist S, Baker D, Tan Hehir CA, Jeromin A, Hanlon D, Song L, Shaw LM, Trojanowski JQ, Weiner MW, Hansson O, Blennow K, ADNI Investigators. PMID: 27694257; PMCID: PMC5089525.
      View in: PubMed   Mentions: 227     Fields:    Translation:Humans
    55. Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment. Neurobiol Aging. 2016 12; 48:172-181. Insel PS, Donohue MC, Mackin RS, Aisen PS, Hansson O, Weiner MW, Mattsson N, Alzheimer's Disease Neuroimaging Initiative. PMID: 27710807.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    56. Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information. Alzheimers Dement (Amst). 2016; 4:76-84. Insel PS, Palmqvist S, Mackin RS, Nosheny RL, Hansson O, Weiner MW, Mattsson N. PMID: 27722193; PMCID: PMC5045949.
      View in: PubMed   Mentions: 31  
    57. Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology. Neurology. 2016 05 17; 86(20):1887-96. Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 27164667; PMCID: PMC4873684.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    58. Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis. Nat Commun. 2016 Mar 07; 7:10918. Mattsson N, Insel PS, Palmqvist S, Stomrud E, van Westen D, Minthon L, Zetterberg H, Blennow K, Hansson O. PMID: 26948379; PMCID: PMC4786682.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    59. PATTERNS OF CLINICALLY SIGNIFICANT COGNITIVE IMPAIRMENT IN HOARDING DISORDER. Depress Anxiety. 2016 Mar; 33(3):211-8. Mackin RS, Vigil O, Insel P, Kivowitz A, Kupferman E, Hough CM, Fekri S, Crothers R, Bickford D, Delucchi KL, Mathews CA. PMID: 26474146; PMCID: PMC5520804.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    60. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimers Dement. 2015 Jul; 11(7):740-56. Jack CR, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, Gunter J, Gutman BA, Holland D, Hua X, Insel P, Kantarci K, Killiany RJ, Krueger G, Leung KK, Mackin S, Maillard P, Malone IB, Mattsson N, McEvoy L, Modat M, Mueller S, Nosheny R, Ourselin S, Schuff N, Senjem ML, Simonson A, Thompson PM, Rettmann D, Vemuri P, Walhovd K, Zhao Y, Zuk S, Weiner M. PMID: 26194310; PMCID: PMC4523217.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    61. Evidence for age-associated cognitive decline from Internet game scores. Alzheimers Dement (Amst). 2015 Jun; 1(2):260-7. Geyer J, Insel P, Farzin F, Sternberg D, Hardy JL, Scanlon M, Mungas D, Kramer J, Mackin RS, Weiner MW. PMID: 27239508; PMCID: PMC4876906.
      View in: PubMed   Mentions: 4  
    62. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. JAMA Neurol. 2015 May; 72(5):554-60. Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 25775167.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    63. Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia. Am J Geriatr Psychiatry. 2016 Feb; 24(2):126-35. Sacuiu S, Insel PS, Mueller S, Tosun D, Mattsson N, Jack CR, DeCarli C, Petersen R, Aisen PS, Weiner MW, Mackin RS, Alzheimer's Disease Neuroimaging Initiative. PMID: 26238228; PMCID: PMC4973623.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    64. Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease. Ann Clin Transl Neurol. 2015 May; 2(5):534-47. Insel PS, Mattsson N, Mackin RS, Kornak J, Nosheny R, Tosun-Turgut D, Donohue MC, Aisen PS, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 26000325; PMCID: PMC4435707.
      View in: PubMed   Mentions: 16     Fields:    
    65. Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly. J Neurosci. 2015 Feb 18; 35(7):3240-7. Song Z, Insel PS, Buckley S, Yohannes S, Mezher A, Simonson A, Wilkins S, Tosun D, Mueller S, Kramer JH, Miller BL, Weiner MW. PMID: 25698758; PMCID: PMC4331637.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    66. Brain structure and function as mediators of the effects of amyloid on memory. Neurology. 2015 Mar 17; 84(11):1136-44. Mattsson N, Insel PS, Aisen PS, Jagust W, Mackin S, Weiner M, Alzheimer's Disease Neuroimaging Initiative. PMID: 25681451; PMCID: PMC4371407.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    67. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis. 2015; 43(3):1007-16. Mackin RS, Insel P, Zhang J, Mohlenhoff B, Galasko D, Weiner M, Mattsson N. PMID: 25125463; PMCID: PMC4350922.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    68. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Brain. 2015 Mar; 138(Pt 3):772-83. Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW, Alzheimer's Disease Neuroimaging Initiative*. PMID: 25541191; PMCID: PMC4339769.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    69. The transitional association between β-amyloid pathology and regional brain atrophy. Alzheimers Dement. 2015 Oct; 11(10):1171-9. Insel PS, Mattsson N, Donohue MC, Mackin RS, Aisen PS, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 25499535; PMCID: PMC4461550.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    70. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging. 2015 Jan; 36(1):273-82. Nosheny RL, Insel PS, Truran D, Schuff N, Jack CR, Aisen PS, Shaw LM, Trojanowski JQ, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 25175807; PMCID: PMC5832349.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    71. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Ann Clin Transl Neurol. 2014 Aug; 1(8):534-43. Mattsson N, Insel PS, Landau S, Jagust W, Donohue M, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner M, Alzheimer's Disease Neuroimaging Initiativea. PMID: 25356425; PMCID: PMC4184556.
      View in: PubMed   Mentions: 56     Fields:    
    72. Emerging β-amyloid pathology and accelerated cortical atrophy. JAMA Neurol. 2014 Jun; 71(6):725-34. Mattsson N, Insel PS, Nosheny R, Tosun D, Trojanowski JQ, Shaw LM, Jack CR, Donohue MC, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 24781145; PMCID: PMC4410966.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    73. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain. 2014 May; 137(Pt 5):1550-61. Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 24625697; PMCID: PMC3999717.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    74. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology. 2014 Mar 11; 82(10):835-41. Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW, Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. PMID: 24523480; PMCID: PMC3959758.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    75. Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. PLoS One. 2014; 9(1):e87747. Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW. PMID: 24498184; PMCID: PMC3909227.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    76. Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. PLoS One. 2013; 8(12):e85443. Mattsson N, Insel P, Tosun D, Zhang J, Jack CR, Galasko D, Weiner M, Alzheimer’s Disease Neuroimaging Initiative. PMID: 24392009; PMCID: PMC3877372.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    77. Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Neurobiol Aging. 2014 Mar; 35(3):614-22. Mattsson N, Insel P, Nosheny R, Trojanowski JQ, Shaw LM, Jack CR, Tosun D, Weiner M, Alzheimer's Disease Neuroimaging Initiative. PMID: 24094581; PMCID: PMC3864623.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    78. Early indications of future cognitive decline: stable versus declining controls. PLoS One. 2013; 8(9):e74062. Rizk-Jackson A, Insel P, Petersen R, Aisen P, Jack C, Weiner M. PMID: 24040166; PMCID: PMC3767625.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    79. Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology. 2013 Mar 26; 80(13):1194-201. Ewers M, Insel PS, Stern Y, Weiner MW, Alzheimer's Disease Neuroimaging Initiative (ADNI). PMID: 23486873; PMCID: PMC3691784.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    80. The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment. Am J Geriatr Psychiatry. 2013 Sep; 21(9):906-14. Mackin RS, Insel P, Tosun D, Mueller SG, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Lee JY, Jack CR, Aisen PS, Petersen RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 23567388; PMCID: PMC5548455.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    81. Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response. Am J Geriatr Psychiatry. 2013 Aug; 21(8):794-802. Mackin RS, Tosun D, Mueller SG, Lee JY, Insel P, Schuff N, Truran-Sacrey D, Arean P, Nelson JC, Weiner MW. PMID: 23567394; PMCID: PMC3732520.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    82. A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 2012 Dec; 6(4):517-27. Gibbons LE, Carle AC, Mackin RS, Harvey D, Mukherjee S, Insel P, Curtis SM, Mungas D, Crane PK, Alzheimer’s Disease Neuroimaging Initiative. PMID: 22644789; PMCID: PMC3684181.
      View in: PubMed   Mentions: 235     Fields:    Translation:Humans
    83. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 2012 Dec; 6(4):502-16. Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, Jones RN, Mukherjee S, Curtis SM, Harvey D, Weiner M, Mungas D, Alzheimer’s Disease Neuroimaging Initiative. PMID: 22782295; PMCID: PMC3806057.
      View in: PubMed   Mentions: 281     Fields:    Translation:Humans
    84. Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking. Alzheimers Dement. 2012 Nov; 8(6):513-9. Durazzo TC, Insel PS, Weiner MW, Alzheimer Disease Neuroimaging Initiative. PMID: 23102121; PMCID: PMC3484322.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    85. Different associations of white matter lesions with depression and cognition. BMC Neurol. 2012 Aug 25; 12:83. Lee JY, Insel P, Mackin RS, Schuff N, Chui H, DeCarli C, Park KH, Mueller SG, Weiner MW. PMID: 22920586; PMCID: PMC3482604.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    86. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012 Sep; 22(9):1993-2004. Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative (ADNI). PMID: 22038908; PMCID: PMC3500862.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    87. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement. 2011 Sep; 7(5):514-20. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 21889115; PMCID: PMC3177162.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    88. Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry. 2012 Apr; 27(4):355-63. Mackin RS, Insel P, Aisen PS, Geda YE, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 21744390; PMCID: PMC3685477.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    89. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology. 2011 Jun; 259(3):844-51. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 21467255; PMCID: PMC3099048.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    90. Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol. 2011 Jan; 68(1):58-66. Schneider LS, Insel PS, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 21220675; PMCID: PMC3259850.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    91. Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol Aging. 2012 May; 33(5):845-55. Schuff N, Tosun D, Insel PS, Chiang GC, Truran D, Aisen PS, Jack CR, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 20855131; PMCID: PMC3032014.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    92. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Dis Assoc Disord. 2009 Jul-Sep; 23(3):260-7. Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. PMID: 19812469; PMCID: PMC2762354.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    93. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006 Mar; 14(3):191-210. Schneider LS, Dagerman K, Insel PS. PMID: 16505124.
      View in: PubMed   Mentions: 261     Fields:    Translation:Humans
    94. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005 Oct 19; 294(15):1934-43. Schneider LS, Dagerman KS, Insel P. PMID: 16234500.
      View in: PubMed   Mentions: 454     Fields:    Translation:Humans
    Philip's Networks
    Concepts (198)
    Derived automatically from this person's publications.
    _
    Co-Authors (51)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _